Brian Eddy
Hematology & Oncology · Anderson, INNPI 1770692568
Payments from drug & device makers
Across 150 payments — averaging $15.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$226
- Johnson & Johnson$199
- Pfizer$193
- Merck$190
- E.r. Squibb & Sons, L.L.C.$167
- AstraZeneca$155
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,08188%
- Education$28612%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 13 | $226 |
| Johnson & Johnson(2 entities) | 8 | $199 |
| Pfizer | 17 | $193 |
| Merck | 14 | $190 |
| E.r. Squibb & Sons, L.L.C. | 12 | $167 |
| AstraZeneca(2 entities) | 10 | $155 |
| Novartis | 9 | $154 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $127 |
| Eisai Inc. | 14 | $126 |
| AbbVie | 3 | $123 |
| Sanofi | 4 | $80 |
| Incyte Corporation | 5 | $74 |
| Amgen | 4 | $67 |
| Bayer | 3 | $42 |
| Daiichi Sankyo Inc. | 3 | $41 |
| Clovis Oncology, Inc. | 3 | $41 |
| Array Biopharma Inc | 2 | $39 |
| Bristol Myers Squibb | 2 | $35 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $34 |
| Seagen Inc. | 2 | $30 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| Sandoz | 2 | $23 |
| Puma Biotechnology, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $19 |
| Mylan Institutional Inc. | 1 | $19 |
| Agios Pharmaceuticals, Inc. | 1 | $18 |
| Tesaro, Inc. | 1 | $16 |
| Medtronic | 1 | $15 |
| Rigel Pharmaceuticals, Inc. | 1 | $14 |
| Lilly USA, LLC | 1 | $12 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
| Verastem, Inc. | 1 | $12 |
| Boehringer Ingelheim | 1 | $12 |
| GSK | 1 | $11 |
How this compares
$2,368 in reported general payments places this provider in the 25th percentile of 224 hematology & oncology providers in Indiana.
Other hematology & oncology in Anderson
- Gregory DurmIndianapolis$22.7M
- Nabil AdraIndianapolis$13.2M
- Attaya SuvannasankhaIndianapolis$8.2M
- Zhentao ZhangFort Wayne$6.4M
- Shadia JalalIndianapolis$4.6M
- Ahad SadiqFort Wayne$4M
- Ruemu BirhirayIndianapolis$4M
- Richard GaynorIndianapolis$3.7M
- Ebenezer KioGoshen$2.8M
- Chandler ParkCorydon$2.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.